Features

Small firms driving antibacterial drugs development

MDR-GNB (Multi-drug resistant gram-negative organisms) continue to pose a threat. New analysis finds that small firms are taking on the baton from big pharma in antibacterial drugs development. more »

Mar 31, 2015 10:12 AM News

Xceleron and Molecular Profiles collaboration – what does it mean for pharma?

Molecular Profiles and Maryland-based Xceleron recently announced a collaboration to assist drug developers with improved efficiency during clinical development. In an exclusive interview with EPM, we found out what this means for pharma. more »

Mar 26, 2015 2:25 PM News

ESCMID and WHO team up for 'Fighting Infection' day

The European Society for Clinical Microbiology and Infectious Diseases (ESCMID) has been joined by the World Health Organisation (WHO) to launch the 7th annual ‘International Day for Fighting Infection’ (April 24th, 2015). more »

Mar 17, 2015 9:31 AM News

Smoking cessation drug not a suicide risk, trials confirm

Findings from the largest review of clinical trials to determine whether patients prescribed the smoking cessation drug Varenicline (brand name Champix in the UK) are at an increased risk of neuropsychiatric events are published. more »

Mar 12, 2015 11:22 AM News

Cancer Drugs Fund cuts don't save money, survey finds

In light of NHS England's plan to remove 25 uses of cancer medicines from the Cancer Drugs Fund (CDF) on 12 March, a new survey has revealed considerable dissatisfaction amongst oncologists with some of the proposed changes. more »

Mar 10, 2015 4:08 PM News

Medical Expo
Built with Metro Publisher™